Index S&P 500
P/E 42.45
EPS (ttm) 5.90
Insider Own 8.82%
Shs Outstand 739.20M
Perf Week 4.60%
Market Cap 185.44B
Forward P/E 28.88
EPS next Y 8.67
Insider Trans -0.05%
Shs Float 675.23M
Perf Month 1.05%
Income 4.40B
PEG 12.49
EPS next Q 1.59
Inst Own 81.80%
Short Float 0.92%
Perf Quarter 9.54%
Sales 26.23B
P/S 7.07
EPS this Y 0.33%
Inst Trans -0.21%
Short Ratio 2.23
Perf Half Y 22.72%
Book/sh 72.16
P/B 3.47
EPS next Y 14.01%
ROA 5.28%
Short Interest 6.20M
Perf Year 11.07%
Cash/sh 9.49
P/C 26.37
EPS next 5Y 3.40%
ROE 8.47%
52W Range 182.09 - 259.00
Perf YTD 8.24%
Dividend Est. 0.97 (0.39%)
P/FCF 33.37
EPS past 5Y 11.31%
ROI 6.30%
52W High -3.32%
Beta 0.83
Dividend TTM 1.02 (0.41%)
Quick Ratio 1.51
Sales past 5Y 8.35%
Gross Margin 58.35%
52W Low 37.52%
ATR (14) 5.65
Dividend Ex-Date Mar 27, 2024
Current Ratio 1.85
EPS Y/Y TTM -36.66%
Oper. Margin 21.32%
RSI (14) 57.03
Volatility 2.42% 1.72%
Employees 63000
Debt/Eq 0.36
Sales Y/Y TTM -15.25%
Profit Margin 16.78%
Recom 1.65
Target Price 273.67
Option/Short Yes / Yes
LT Debt/Eq 0.31
EPS Q/Q -25.02%
Payout 16.45%
Rel Volume 1.18
Prev Close 253.11
Sales Surprise 3.09%
EPS Surprise 11.84%
Sales Q/Q -19.13%
Earnings Apr 23 BMO
Avg Volume 2.78M
Price 250.41
SMA20 2.72%
SMA50 0.68%
SMA200 9.74%
Trades
Volume 3,344,940
Change -1.07%
Date
Action
Analyst
Rating Change
Price Target Change
Apr-17-24 Upgrade
HSBC Securities
Hold → Buy
$280
Jan-24-24 Downgrade
Barclays
Overweight → Equal Weight
$240
Dec-18-23 Initiated
HSBC Securities
Hold
Dec-13-23 Resumed
Wolfe Research
Peer Perform
Dec-07-23 Downgrade
Goldman
Buy → Neutral
$215 → $205
Jul-19-23 Initiated
Raymond James
Outperform
$270
May-01-23 Initiated
SVB Securities
Outperform
$300
Apr-26-23 Downgrade
BofA Securities
Buy → Neutral
$310 → $250
Apr-18-23 Upgrade
Wells Fargo
Equal Weight → Overweight
$275 → $285
Jan-05-23 Downgrade
Credit Suisse
Outperform → Neutral
$315 → $300
Dec-14-22 Initiated
Deutsche Bank
Buy
$310
Oct-24-22 Downgrade
The Benchmark Company
Buy → Hold
$325
Aug-25-22 Initiated
Credit Suisse
Outperform
$340
Aug-17-22 Resumed
Bernstein
Outperform
$330 → $340
Jul-20-22 Initiated
UBS
Buy
$297
Jun-01-22 Upgrade
RBC Capital Mkts
Sector Perform → Outperform
$299 → $310
Apr-25-22 Downgrade
Wells Fargo
Overweight → Equal Weight
$265
Jan-11-22 Initiated
Bernstein
Outperform
$365
Oct-15-21 Resumed
Cowen
Outperform
$350
Sep-10-21 Reiterated
BofA Securities
Buy
$340 → $360
Show Previous Ratings
Apr-24-24 09:52AM
03:01AM
01:02AM
Apr-23-24 10:17PM
(Thomson Reuters StreetEvents) +7.21%
04:41PM
12:21PM
Loading…
12:21PM
(The Wall Street Journal)
12:07PM
(Associated Press Finance)
11:39AM
11:33AM
(Investor's Business Daily)
11:29AM
10:53AM
10:44AM
09:30AM
07:31AM
07:10AM
06:59AM
Loading…
06:59AM
06:55AM
06:26AM
06:07AM
(Associated Press Finance)
06:00AM
05:37AM
Apr-19-24 09:52AM
Apr-18-24 04:27PM
12:10PM
10:58AM
09:15AM
Apr-17-24 08:00AM
Apr-13-24 12:16PM
Apr-12-24 12:30PM
Apr-11-24 04:30PM
12:19PM
Loading…
12:19PM
Apr-05-24 06:00PM
Apr-04-24 09:00AM
08:00AM
Apr-02-24 06:15PM
Mar-28-24 03:41AM
Mar-27-24 06:00PM
09:30AM
08:00AM
Mar-26-24 06:15PM
Mar-21-24 04:15PM
10:25AM
09:00AM
Mar-20-24 06:00PM
08:00AM
Mar-18-24 06:15PM
Mar-13-24 10:23AM
08:05AM
Mar-12-24 06:00PM
Mar-11-24 06:15PM
Mar-06-24 06:00AM
Mar-05-24 06:00PM
Mar-04-24 09:06AM
Mar-02-24 10:42AM
Mar-01-24 09:00AM
Feb-29-24 11:30AM
Feb-28-24 06:00PM
Feb-27-24 04:15PM
Feb-25-24 02:38PM
Feb-22-24 09:01PM
04:15PM
Feb-21-24 04:15PM
Feb-17-24 01:28PM
Feb-12-24 03:03PM
Feb-09-24 01:40AM
Feb-05-24 07:30AM
Feb-01-24 11:08AM
Jan-30-24 11:14PM
(Thomson Reuters StreetEvents)
01:26PM
11:44AM
11:08AM
09:30AM
07:10AM
06:34AM
06:17AM
(Associated Press Finance)
06:00AM
Jan-29-24 12:56PM
08:36AM
07:30AM
Jan-26-24 08:10AM
Jan-25-24 09:15AM
Jan-23-24 10:00AM
Jan-22-24 06:00PM
Jan-19-24 04:27AM
Jan-17-24 12:10PM
Jan-16-24 06:15PM
Jan-10-24 06:00PM
Jan-09-24 06:15PM
09:19AM
07:30AM
Jan-08-24 04:15PM
Jan-03-24 06:00PM
Jan-02-24 06:15PM
05:00PM
Dec-27-23 06:15PM
Dec-25-23 08:14PM
Dec-21-23 04:30PM
09:28AM
Dec-19-23 10:56AM
Dec-18-23 06:00PM
Danaher Corp. engages in the design, manufacture, and marketing of professional, medical, industrial, and commercial products and services. It operates through the following segments: Biotechnology, Life Sciences, Diagnostics, and Environmental and Applied Solutions. The Biotechnology segment includes the bioprocessing and discovery and medical businesses and offers a range of tools, consumables, and services. The Life Sciences segment offers a range of instruments and consumables to study the basic building blocks of life, including DNA and RNA. The Diagnostics segment offers clinical instruments, reagents, consumables, software, and services used to diagnose disease and make treatment decisions. The Environmental and Applied Solution segment offers products and services that help protect important resources and keep global food and water supplies safe. The company was founded by Steven M. Rales and Mitchell P. Rales in 1984 and is headquartered in Washington, DC.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Raskas Daniel SVP - Corporate Development Feb 26 '24 Option Exercise 58.48 23,757 1,389,309 61,859 Feb 27 05:01 PM Raskas Daniel SVP - Corporate Development Feb 26 '24 Sale 252.00 23,757 5,986,764 38,102 Feb 27 05:01 PM LOHR WALTER G Director Feb 15 '24 Option Exercise 52.56 3,289 172,870 17,418 Feb 16 05:01 PM LOHR WALTER G Director Feb 15 '24 Sale 251.15 3,289 826,032 14,129 Feb 16 05:01 PM Couchara Georgeann SVP, Human Resources Feb 13 '24 Option Exercise 70.71 2,622 185,414 6,022 Feb 14 05:00 PM Couchara Georgeann SVP, Human Resources Feb 13 '24 Sale 242.67 2,622 636,290 4,244 Feb 14 05:00 PM List Teri Director Feb 06 '24 Option Exercise 52.56 3,289 172,870 23,015 Feb 08 05:00 PM List Teri Director Feb 06 '24 Sale 248.32 3,289 816,724 19,726 Feb 08 05:00 PM Gutierrez-Ramos Jose-Carlos SVP, Chief Science Officer Aug 21 '23 Sale 250.54 590 147,819 6,939 Aug 22 05:00 PM Raskas Daniel SVP - Corporate Development Jul 28 '23 Option Exercise 56.70 11,213 635,777 49,501 Aug 01 05:03 PM Zerhouni Elias A. Director Jul 28 '23 Option Exercise 50.80 3,490 177,292 30,523 Aug 01 05:02 PM SCHWIETERS JOHN T Director Jul 28 '23 Option Exercise 50.80 3,490 177,292 22,583 Aug 01 05:02 PM FILLER LINDA Director Jul 28 '23 Option Exercise 59.17 2,922 172,895 41,074 Aug 01 05:00 PM Raskas Daniel SVP - Corporate Development Jul 28 '23 Sale 260.65 11,213 2,922,652 38,288 Aug 01 05:03 PM FILLER LINDA Director Jul 28 '23 Sale 260.25 10,190 2,651,978 38,152 Aug 01 05:00 PM Weidemanis Joakim Executive Vice President Jul 26 '23 Option Exercise 56.70 22,439 1,272,291 111,128 Jul 27 05:01 PM List Teri Director Jul 26 '23 Option Exercise 50.80 3,490 177,292 20,984 Jul 27 05:00 PM Weidemanis Joakim Executive Vice President Jul 26 '23 Sale 263.42 22,439 5,910,832 88,689 Jul 27 05:01 PM List Teri Director Jul 26 '23 Sale 263.30 3,490 918,917 17,494 Jul 27 05:00 PM Raskas Daniel SVP - Corporate Development May 31 '23 Option Exercise 57.90 19,847 1,149,141 58,520 Jun 01 05:00 PM Raskas Daniel SVP - Corporate Development May 31 '23 Sale 228.50 19,847 4,535,040 38,673 Jun 01 05:00 PM LOHR WALTER G Director May 05 '23 Option Exercise 50.80 3,490 177,292 15,605 May 08 05:08 PM LOHR WALTER G Director May 05 '23 Sale 240.88 3,490 840,685 12,115 May 08 05:08 PM Weidemanis Joakim Executive Vice President May 04 '23 Option Exercise 57.90 9,934 575,179 101,357 May 05 05:01 PM Weidemanis Joakim Executive Vice President May 04 '23 Sale 245.27 9,934 2,436,512 91,423 May 05 05:01 PM Couchara Georgeann SVP, Human Resources May 04 '23 Sale 245.27 695 170,463 1,565 May 05 05:00 PM Gutierrez-Ramos Jose-Carlos SVP, Chief Science Officer May 01 '23 Sale 242.19 500 121,096 7,529 May 02 05:01 PM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite